Norris Medicines Limited
BSE: NORRIS
Prev Close
17.44
Open Price
18
Volume
179
Today Low / High
17.9 / 18
52 WK Low / High
14.78 / 24.16
Range
17 - 19
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 18, reflecting a change of 0.56 (3.21101%). The expected target range on the BSE is 17 - 19. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Norris Medicines Limited Graph
Norris Medicines Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Norris Medicines Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 18.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 18.00 | 18.18 | 16.36 - 20.00 |
| 18.36 | 14.69 - 22.03 | ||
| 18.54 | 12.98 - 24.10 | ||
| Bearish Scenario | 18.00 | 17.82 | 16.04 - 19.60 |
| 17.64 | 14.11 - 21.17 | ||
| 17.46 | 12.22 - 22.70 |
Overview of Norris Medicines Limited
ISIN
INE744C01029
Industry
Medical - Pharmaceuticals
Vol.Avg
1,521
Market Cap
180,012,600
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 5.64 Cr | 2.70 Cr | 2.94 Cr | 0.5210 | 0.00 Cr | 0.00 Cr | 1.12 Cr | -1.19 Cr | -1.19 | -0.18 Cr | -0.2106 |
| 2023-03-31 | 8.36 Cr | 3.52 Cr | 4.84 Cr | 0.5785 | 0.00 Cr | 2.30 Cr | 0.30 Cr | -1.75 Cr | -1.75 | 0.93 Cr | -0.2093 |
| 2022-03-31 | 9.44 Cr | 5.73 Cr | 3.71 Cr | 0.3934 | 0.00 Cr | 2.33 Cr | -0.72 Cr | -3.26 Cr | -3.26 | -0.06 Cr | -0.3458 |
| 2021-03-31 | 12.25 Cr | 8.91 Cr | 3.34 Cr | 0.2729 | 0.00 Cr | 0.00 Cr | -2.41 Cr | -4.96 Cr | -4.96 | -1.74 Cr | -0.4050 |
| 2020-03-31 | 7.84 Cr | 4.75 Cr | 3.09 Cr | 0.3938 | 0.00 Cr | 3.23 Cr | -2.85 Cr | -2.84 Cr | -2.84 | -2.12 Cr | -0.3622 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.04 Cr | 14.19 Cr | 27.82 Cr | -13.6300 Cr | 21.52 Cr | 21.49 Cr | 4.33 Cr | 5.79 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 9.2256 Cr |
| 2023-03-31 | 0.02 Cr | 13.69 Cr | 26.13 Cr | -12.4433 Cr | 21.40 Cr | 21.38 Cr | 3.20 Cr | 6.47 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 7.7046 Cr |
| 2022-03-31 | 0.02 Cr | 14.19 Cr | 24.88 Cr | -10.6938 Cr | 21.08 Cr | 21.06 Cr | 2.43 Cr | 7.07 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 6.7837 Cr |
| 2021-03-31 | 0.02 Cr | 19.79 Cr | 27.22 Cr | -7.4303 Cr | 18.39 Cr | 18.36 Cr | 5.32 Cr | 7.67 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 11.6940 Cr |
| 2020-03-31 | 0.06 Cr | 20.56 Cr | 23.02 Cr | -2.4684 Cr | 17.92 Cr | 17.86 Cr | 4.02 Cr | 8.25 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 8.0415 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.1698 Cr | 0.0507 Cr | -0.2033 Cr | 0.1686 Cr | 0.0172 Cr | 0.0376 Cr | -0.0011 Cr | -1.1868 Cr | 0.1665 Cr | 0.0000 Cr | -1.1351 Cr |
| 2023-03-31 | 1.1995 Cr | -0.0218 Cr | -1.1760 Cr | 1.1697 Cr | 0.0017 Cr | 0.0203 Cr | -0.0299 Cr | -1.7495 Cr | 0.3243 Cr | 0.0000 Cr | -0.7776 Cr |
| 2022-03-31 | -1.0094 Cr | -0.0889 Cr | 1.0963 Cr | -1.0648 Cr | -0.0021 Cr | 0.0186 Cr | -0.0554 Cr | -3.2635 Cr | 2.5778 Cr | 0.0000 Cr | 2.6815 Cr |
| 2021-03-31 | 1.1136 Cr | -0.0619 Cr | -1.0945 Cr | 1.0256 Cr | -0.0428 Cr | 0.0207 Cr | -0.0880 Cr | -4.9619 Cr | 0.5400 Cr | 0.0000 Cr | -1.0968 Cr |
| 2020-03-31 | -2.8837 Cr | 0.0050 Cr | 2.8596 Cr | -2.9611 Cr | -0.0192 Cr | 0.0635 Cr | -0.0774 Cr | -2.8411 Cr | 3.7418 Cr | 0.0000 Cr | -0.2456 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.72 Cr | 0.17 Cr | 0.55 Cr | 0.7619 | -0.29 Cr | -0.37 Cr | -0.37 | -0.15 Cr | -0.5052 |
| 2024-03-31 | 1.49 Cr | 0.22 Cr | 1.27 Cr | 0.8515 | 0.35 Cr | 0.17 Cr | 0.17 | 0.50 Cr | 0.1174 |
| 2023-12-31 | 0.65 Cr | 0.05 Cr | 0.59 Cr | 0.9161 | -0.18 Cr | -0.27 Cr | -0.27 | -0.03 Cr | -0.4185 |
| 2023-09-30 | 2.56 Cr | 2.02 Cr | 0.53 Cr | 0.2089 | -0.39 Cr | -0.48 Cr | -0.48 | -0.25 Cr | -0.1864 |
| 2023-06-30 | 0.95 Cr | 0.36 Cr | 0.58 Cr | 0.6171 | -0.53 Cr | -0.61 Cr | -0.61 | -0.37 Cr | -0.6497 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | -0.04 Cr | 0.08 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 13.63 Cr |
| 2024-03-31 | 0.04 Cr | 0.00 Cr | 0.04 Cr | 1.07 Cr | 4.33 Cr | 6.14 Cr | 5.79 Cr | 14.15 Cr | 27.78 Cr |
| 2023-12-31 | -0.02 Cr | 0.04 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.02 Cr | 0.00 Cr | 0.02 Cr | 1.01 Cr | 3.06 Cr | 4.68 Cr | 6.18 Cr | 13.15 Cr | 26.69 Cr |
| 2023-06-30 | -0.02 Cr | 0.04 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | -0.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -0.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | -0.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-06-30 | -0.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born: 1963
Gender: Not Specified
Year Born: 1970
Gender: Not Specified
Year Born: 1956
Gender: female
Year Born:
Gender: male
Year Born: 1976
FAQs about Norris Medicines Limited
The CEO is Vimal Dhirendra Shah.
The current price is ₹18.00.
The range is ₹14.78-24.16.
The market capitalization is ₹18.00 crores.
The P/E ratio is -92.98.
The company operates in the Healthcare sector.
Overview of Norris Medicines Limited (ISIN: INE744C01029) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹18.00 crores and an average daily volume of 1,521 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.